LIVINGSTON, N.J.--(BUSINESS WIRE)--Robert S. Mills, president and chief executive officer of Columbia Laboratories, Inc. (NASDAQ: CBRX), will present at the upcoming UBS Global Generic & Specialty Pharmaceuticals Conference.
LIVINGSTON, N.J.--(BUSINESS WIRE)--Robert S. Mills, president and chief executive officer of Columbia Laboratories, Inc. (NASDAQ: CBRX), will present at the upcoming UBS Global Generic & Specialty Pharmaceuticals Conference.
